Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
VRC 329: A Phase I Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (STEMos1) With and Without ALFQ Adjuvant in Healthy Adults
Background: Influenza (flu) is a contagious respiratory illness caused by viruses. Flu symptoms can range from mild to severe, and the illness can be fatal. V…
Influenza PreventionPandemic Influenza Prevention
Estimated
~$10 – $5,625
National Institute of Allergy and Infectious Diseases (NIAID)NCT07111078
Phase 1
VRC 328: A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Background: Vaccines help the body learn to fight infections. Some vaccines are combined with adjuvants, which are added substances that make vaccines work be…
Influenza PreventionSeasonal Influenza
Estimated
~$10 – $5,625
National Institute of Allergy and Infectious Diseases (NIAID)NCT06863142